Elkington And Fife patent opposition analysis

The comprehensive analysis of Elkington And Fife opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Elkington And Fife

Patent NumberTitleApplicantOpposition DateOpposition Company
Crystalline Forms Of N-[4-(Chlorodifluoromethoxy)Phenyl]-6-[(3R)-3-Hydroxypyrrolidin-1-Yl]-5-(1H-Pyrazol-5-Yl)Pyridine-3-CarboxamideNOVARTIS AGNov 5, 2026ELKINGTON AND FIFE
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD.Oct 27, 2026GENERICS UK
Methods Of Schizophrenia TreatmentINTRA-CELLULAR THERAPIES, INC.Oct 23, 2026SANDOZ
New Therapeutic Combinations For The Treatment Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIM INTERNATIONAL GMBHOct 22, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Patch Product Based On Natural PolymersBAKEL S.P.A.Oct 21, 2026ELKINGTON AND FIFE
Biphenyl Sulfonamide Compounds For The Treatment Of Kidney Diseases Or DisordersTRAVERE THERAPEUTICS, INC.Oct 16, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Sanitary ArticleESSITY HYGIENE AND HEALTH AKTIEBOLAGOct 14, 2026THE PROCTER & GAMBLE
Esketamine For The Treatment Of DepressionJANSSEN PHARMACEUTICA NVOct 6, 2026ELKINGTON AND FIFE
Methods Of Reducing The Risk Of Cardiovascular Events In A SubjectAMARIN PHARMACEUTICALS IRELAND LIMITEDSep 30, 2026ELKINGTON AND FIFE
Methods Of Reducing The Risk Of Cardiovascular Events In A SubjectAMARIN PHARMACEUTICALS IRELAND LIMITEDSep 30, 2026ELKINGTON AND FIFE